King LC - Search Results

1

Comparative in vitro and in vivo benzo[a]pyrene-DNA adduct formation and its relationship to CYP1A activity in two species of ictalurid catfish.

Ploch SA, King LC, Kohan MJ, Di Giulio RT. Ploch SA, et al. Among authors: king lc. Toxicol Appl Pharmacol. 1998 Mar;149(1):90-8. doi: 10.1006/taap.1997.8359. Toxicol Appl Pharmacol. 1998. PMID: 9512731

2

A quantitative comparison of dibenzo[a,l]pyrene-DNA adduct formation by recombinant human cytochrome P450 microsomes.

King LC, Adams L, Allison J, Kohan MJ, Nelson G, Desai D, Amin S, Ross JA. King LC, et al. Mol Carcinog. 1999 Oct;26(2):74-82. Mol Carcinog. 1999. PMID: 10506751

3

An evaluation of the mutagenicity, metabolism, and DNA adduct formation of 5-nitrobenzo[b]naphtho[2,1-d]thiophene.

King LC, Kohan MJ, Brooks L, Nelson GB, Ross JA, Allison J, Adams L, Desai D, Amin S, Padgett W, Lambert GR, Richard AM, Nesnow S. King LC, et al. Chem Res Toxicol. 2001 Jun;14(6):661-71. doi: 10.1021/tx0001373. Chem Res Toxicol. 2001. PMID: 11409936

4

Detection of DNA adducts in developing CD4+ CD8+ thymocytes and splenocytes following in utero exposure to benzo[a]pyrene.

Rodriguez JW, Kohan MJ, King LC, Kirlin WG. Rodriguez JW, et al. Among authors: king lc. Immunopharmacol Immunotoxicol. 2002 Aug;24(3):365-81. doi: 10.1081/iph-120014723. Immunopharmacol Immunotoxicol. 2002. PMID: 12375734

5

Metabolism of 1-nitropyrene by human, rat, and mouse intestinal flora: mutagenicity of isolated metabolites by direct analysis of HPLC fractions with a microsuspension reverse mutation assay.

King LC, Kohan MJ, George SE, Lewtas J, Claxton LD. King LC, et al. J Toxicol Environ Health. 1990 Nov;31(3):179-92. doi: 10.1080/15287399009531447. J Toxicol Environ Health. 1990. PMID: 2231777

6

Modulation of 2,6-dinitrotoluene genotoxicity by alachlor treatment of Fischer 344 rats.

George SE, Allison JC, Brooks LR, Eischen BT, Kohan MJ, Warren SH, King LC. George SE, et al. Among authors: king lc. Environ Mol Mutagen. 1998;31(3):274-81. doi: 10.1002/(sici)1098-2280(1998)31:3<274::aid-em9>3.0.co;2-k. Environ Mol Mutagen. 1998. PMID: 9585266

7

Mutagenicity of 1-nitropyrene metabolites from lung S9.

King LC, Kohan MJ, Ball LM, Lewtas J. King LC, et al. Cancer Lett. 1984 Apr;22(3):255-62. doi: 10.1016/0304-3835(84)90160-5. Cancer Lett. 1984. PMID: 6713366

8

Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.

Nesnow S, Davis C, Padgett W, George M, Lambert G, Meyers F, Allison J, Adams L, King LC. Nesnow S, et al. Among authors: king lc. Chem Res Toxicol. 1998 Dec;11(12):1596-607. doi: 10.1021/tx9801561. Chem Res Toxicol. 1998. PMID: 9860506

9

Evaluation of the release of mutagens from diesel particles in the presence of physiological fluids.

King LC, Kohan MJ, Austin AC, Claxton LD, Huisingh JL. King LC, et al. Environ Mutagen. 1981;3(2):109-21. doi: 10.1002/em.2860030203. Environ Mutagen. 1981. PMID: 6165576

10

Evaluation of the release of mutagens and 1-nitropyrene from diesel particles in the presence of lung macrophages in culture.

King LC, Loud K, Tejada SB, Kohan MJ, Lewtas J. King LC, et al. Environ Mutagen. 1983;5(4):577-88. doi: 10.1002/em.2860050407. Environ Mutagen. 1983. PMID: 6347680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters